Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
A Study of Strategies to Improve Schizophrenia Treatment
NCT00156637 · View on ClinicalTrials.gov ↗
Study Summary
The goal of this project is to translate research findings about key aspects of antipsychotic treatment into routine care through a multi-component intervention, focusing on improving two aspects of medication management that are directly linked to patient outcomes: 1) monitoring for potentially serious metabolic side effects of newer antipsychotic medication, and 2) increasing the appropriate use of clozapine for treatment-refractory patients.
Conditions Studied
Interventions
- BEHAVIORAL Team-Based Quality Improvement Intervention
- BEHAVIORAL Opinion Leader Intervention
- BEHAVIORAL Team Based Quality Improvement
Study Locations (4)
Arkansas
- Veterans Health Care System of the Ozarks, Fayetteville, AR — Fayetteville
- Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR — No. Little Rock
Ohio
- Dayton VA Medical Center, Dayton, OH — Dayton
Texas
- Michael E. DeBakey VA Medical Center, Houston, TX — Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2005-06 |
| Est. Completion | 2008-03 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00156637
The ClinicalTrials.gov registry entry for NCT00156637 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 158 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 3 interventions — of which Team-Based Quality Improvement Intervention is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT00156637 reports 4 study locations spanning 3 distinct geographic areas — top geographies include Arkansas, Ohio, Texas. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT00156637 about?
NCT00156637 is a clinical study titled "A Study of Strategies to Improve Schizophrenia Treatment". The goal of this project is to translate research findings about key aspects of antipsychotic treatment into routine care through a multi-component intervention, focusing on improving two aspects of medication management that are directly linked to patient outcomes: 1) monitoring for potentially ser...
What is the current status of trial NCT00156637?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2005-06. Estimated completion is 2008-03.
What conditions does trial NCT00156637 study?
This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT00156637?
The interventions under investigation include: Team-Based Quality Improvement Intervention (BEHAVIORAL), Opinion Leader Intervention (BEHAVIORAL), Team Based Quality Improvement (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT00156637?
This trial is sponsored by US Department of Veterans Affairs, which has 158 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT00156637 being conducted?
This trial has 4 study locations across Arkansas, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.